- Report
- February 2026
- 148 Pages
Global
From €2688EUR$2,999USD£2,306GBP
€3584EUR$3,999USD£3,075GBP
- Report
- January 2026
- 192 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- January 2026
- 185 Pages
Global
From €4033EUR$4,500USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- August 2026
- 164 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- October 2025
- 160 Pages
Global
From €2832EUR$3,160USD£2,430GBP
€3540EUR$3,950USD£3,037GBP
- Report
- June 2026
- 192 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- August 2026
- 129 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- May 2026
- 400 Pages
Global
From €4435EUR$4,949USD£3,805GBP
- Report
- May 2026
- 144 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- January 2026
- 150 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- February 2026
- 194 Pages
Global
From €4477EUR$4,995USD£3,840GBP
- Report
- October 2025
- 160 Pages
Global
From €2832EUR$3,160USD£2,430GBP
€3540EUR$3,950USD£3,037GBP
- Report
- October 2025
- 160 Pages
Global
From €2832EUR$3,160USD£2,430GBP
€3540EUR$3,950USD£3,037GBP
- Report
- September 2025
- 60 Pages
United States
From €5332EUR$5,950USD£4,575GBP
- Report
- April 2026
- 138 Pages
Global
From €2688EUR$2,999USD£2,306GBP
€3584EUR$3,999USD£3,075GBP
- Report
- June 2026
- 195 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP

The Artificial Organ market is a subset of the Biomaterials industry, which focuses on the development of materials for use in medical applications. Artificial organs are designed to replace or supplement the function of a damaged or missing organ, and can be made from a variety of materials, including polymers, metals, and ceramics. These materials are chosen for their biocompatibility, durability, and ability to interact with the body's natural systems.
The Artificial Organ market is driven by advances in medical technology, as well as the increasing prevalence of chronic diseases and organ failure. The market is expected to grow in the coming years, as more people seek out treatments for their conditions.
Companies in the Artificial Organ market include Abiomed, SynCardia Systems, and WorldHeart Corporation. Show Less Read more